Purchasing agreement in the US

Summary by AI ^BETAClose X

Inspiration Healthcare Group plc announced that its US subsidiary, Airon Corporation, has secured a significant three-year purchasing agreement with a large US healthcare provider, marking a key step in Airon's US expansion. The agreement includes an initial order for 150 units of its Model A and Neo ventilators and accessories, establishing a new long-term revenue stream that supports the company's goal of doubling Airon's revenue within five years, with further potential from consumables and service.

Disclaimer*

Inspiration Healthcare Group PLC

28 January 2026

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

Purchasing agreement in the US

Partnership accelerates Airon's US expansion

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company, announces that its US subsidiary, Airon Corporation ("Airon"), has entered into a significant new three-year purchasing agreement with a large US healthcare provider. This marks an important milestone for Airon's continued expansion in the US market.

Under the terms of the agreement, Airon will receive an initial order for 150 units of its Model A and Neo ventilators and accessories, reflecting a significant expansion to its installed base in the US.

This contract delivers a new long-term high quality revenue stream for Airon and directly supports Inspiration Healthcare's strategic goal of doubling Airon revenue within five years. Beyond initial equipment sales, the agreement includes expectations for ongoing consumables and service revenue, substantially increasing the lifetime value of the partnership.

Raffi Stepanian, CEO of Inspiration Healthcare, said: "This agreement validates our technology and execution capabilities on a national scale and is a transformative moment for Airon and for Inspiration Healthcare's US ambitions. We are pursuing further similar opportunities as part of our growth strategy for Airon."

Enquiries:

Inspiration Healthcare Group plc		Tel: +44 (0)330 175 0000
Raffi Stepanian, Chief Executive Officer
Alan Olby, Chief Financial Officer

Panmure Liberum (Nominated Adviser & Broker)			Tel: +44 (0)20 3100 2000
Will Goode Emma Earl
Mark Rogers

Walbrook PR Ltd (Media & IR)	Tel: +44 (0)20 7933 8780 or inspirationhealthcare@walbrookpr.com
Anna Dunphy		Mob: +44 (0) 7876 741 001
Rachel Broad		Mob: +44 (0) 7747 515 393

About Inspiration Healthcare

Inspiration Healthcare (AIM: IHC) designs, manufactures and markets pioneering medical technology. Based in the UK, the Company specialises in neonatal intensive care medical devices, which are addressing a critical need to help to save the lives and improve the outcomes of patients, starting with the very first breaths of life.

The Company has a broad portfolio of its own products and complementary distributed products, for use in neonatal intensive care designed to support even the most premature babies throughout their hospital stay. Its own branded products range from highly sophisticated capital equipment such as ventilators for life support through to single-use disposables.

The Company sells its products directly to hospitals and healthcare providers in the UK and Ireland, where it also distributes a range of advanced medical technologies for infusion therapy. In the rest of the world the Company has an established network of distribution partners around the world giving access to more than 75 countries.

The Company operates in the UK from its world-class Manufacturing and Technology Centre in Croydon, South London and in the USA from its facility in Melbourne, Florida.

Further information on Inspiration Healthcare can be found at www.inspirationhealthcaregroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END